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demonstrated that cofactor binding was critical not only
for activation of the HIV-1 LTR but also for TAR binding
in vivo. Two observations are relevant. (1) While full-
length Tat is able to target a heterologous protein to
TAR RNA in vivo, this activity is blocked by mutation
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not only of the ARM but also of the cofactor-binding
domain. (2) Tat can activate transcription effectively
when targeted to the HIV-1 LTR by fusion to a heterolo-Shortly after the first molecular clones of human immu-
gous RNA-binding domain. In this context, the ARM isnodeficiency virus type 1 (HIV-1) were obtained, it be-
dispensable for Tat function while the cofactor-bindingcame apparent that the genomic organization of this
domain remains essential.human retroviral pathogen was significantly more com-
The finding that Tat could activate the HIV-1 LTR ef-plex than seen in the oncogenic murine and avian vi-
fectively when targeted to a heterologous RNA se-ruses that had previously provided the focus of retroviral
quence substituted in place of TAR also provided two
research. While the efficient replication of these animal
other insights into Tat function. First, this result clearly
retroviruses is dependent only on the biological activity
demonstrated that the sole role of TAR was to recruit
of the prototypic gag, pol, and env gene products, HIV-1
Tat, and any associated cellular proteins, to the HIV-1
was found to express six additional small proteins LTR promoter. Second, the observation that Tat is un-
whose purpose was initially entirely unclear. It soon able to activate transcription from the wild-type HIV-1
emerged that two of these novel proteins, termed Tat LTR in mouse cells, yet is fully active when targeted
and Rev, were essential for HIV-1 replication while a to the LTR via an inserted heterologous RNA target,
third, termed Vif, was critical in many culture settings, demonstrated that the cellular factors required for acti-
including in primary human lymphocytes. The final three vation of the HIV-1 LTR promoter are available to bind
auxiliary proteins, termed Nef, Vpr, and Vpu, proved Tat in mouse cells but recruitment to TAR is defective
to have quite modest phenotypes in most cell culture (Alonso et al., 1992). Overall, these studies therefore
assays. However, regardless of their in vitro phenotype, suggested that the role of Tat was to recruit a cellular
it seemed certain that all of these novel viral proteins cofactor(s) to TAR in a process that involved Tat binding
would contribute to efficient HIV-1 replication, and hence to the TAR bulge and cofactor binding to the TAR loop.
pathogenesis, in vivo. The HIV-1 auxiliary proteins there- This recruitment then resulted in activated transcription
fore rapidly became the subject of intense scientific from the HIV-1 LTR. In mouse cells, the equivalent cofac-
analysis. This process has now begun to yield insights tor was present and could still bind Tat but, for unknown
into not only the molecular mechanisms underlying the reasons, the resultant Tat±cofactor complex was unable
HIV-1 replication cycle but also, and more generally, to recognize TAR. Evidence that this cofactor was likely
to be a single protein came from the finding that intro-into fundamental aspects of the molecular biology of
duction of human chromosome 12 into mouse cells waseukaryotic cells.
able to rescue Tat function partially (Alonso et al., 1992).
Research into the mechanism used by Tat to activateTat: Transcriptional Activation via an RNA Target
the HIV-1 LTR gave the surprising result that the levelThe Tat protein is a potent transcriptional activator of
of transcription initiation from the LTR was essentiallythe HIV-1 long terminal repeat (LTR) promoter element
equivalent in the presence or absence of Tat. However,and is essential for viral replication in almost all culture
in the absence of Tat, these initiated transcripts almostsettings (reviewed by Cullen, 1995). The most surprising,
all terminated prematurely, within z200 nucleotides ofand still unique, aspect of Tat function is that this protein
the transcription start site (Kao et al., 1987). In contrast,
acts via an RNA structure, termed TAR, located immedi-
in the presence of Tat, elongation was found to be effi-
ately 39 to the LTR transcription start site. The TAR
cient, thus suggesting that Tat acted to promote the
element forms a 59-nucleotide RNA stem-loop structure processivity of initiated RNA polymerase II (Pol II) mole-
that presents two critical sequence elements, i.e., a ter- cules. Although the regulation of Pol II processivity re-
minal hexanucleotide loop and a three-nucleotide U-rich mains incompletely understood, this activity is known
bulge located four nucleotides 59 to the loop. In vitro to be modulated by the phosphorylation state of the
analysis demonstrated that Tat can directly bind to the C-terminal domain (CTD) of Pol II, which consists of
U-rich bulge present in TAR. However, this interaction tandem reiterationsof a serine-rich 7 aa repeat. In partic-
is inefficient and is also independent of the TAR loop, ular, the CTD is not phosphorylated when Pol II is bound
even though both the bulge and the loop of TAR are at the promoter but hyperphosphorylated on efficiently
critical for Tat function in vivo. elongating Pol II molecules. It is therefore believed that
Mutational analysis of the short, z86 aa Tat protein CTD phosphorylation is critical for Pol II release from
revealed the presence of two functional domains. These the promoter and for processive transcription. Could
are a cofactor-binding domain, extending from near the Tat be acting by enhancing the phosphorylation state
amino terminus to residue 48, and an arginine-rich RNA- of the Pol II CTD? Two findings suggested that this might
binding motif (ARM), extending from residue 49 to 58, indeed be the case. First, removal of the CTD was found
that also acts as a nuclear localization signal (NLS) (re- to block the ability of Pol II to respond to Tat, and sec-
ond, Tat function was found to be effectively inhibitedviewed by Cullen, 1995). Genetic analysis of Tat function
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LTR promoter, a process that requires binding of Tat to
the TAR bulge and of cyclin T to the TAR loop (Figure
1). The cyclin T±associated CDK9 kinase then induces
phosphorylation of the CTD of Pol II, and perhaps other
pol II±associated proteins, leading to a transition from
nonprocessive to processive transcription.
The mechanism of transcriptionactivation of theHIV-1
LTR by Tat may therefore be close to resolution. Re-
maining questions include whether the Pol II CTD is
the only target for P-TEFb and whether other P-TEFb
subunits play a critical role in this process. It is also
interesting to speculate as to why the HIV-1 LTR has
evolved to promote the initiation of almost entirely non-
processive transcription complexes that must then be
rescued by Tat, when transcription complexes initiated
by LTRs found in most other retroviruses elongate effec-
tively without such rescue. While it is tempting to sug-
gest that this property may somehow facilitate the es-
tablishment of HIV-1 latency, this must be viewed as
little more than speculation at present.
Figure 1. Model for the Assembly of the Tat±cyclin T±CDK9 Hetero-
trimer onto the HIV-1 TAR Element
Rev: Nuclear RNA Export Factor
The large majority of genes in higher eukaryotes exist
in the form of multiple coding exons separated by non-by DRB, a nucleoside analog that functions both as a
selective kinase inhibitor and as an inhibitor of transcrip- coding, intronic regions. These genes are therefore tran-
scribed in the form of pre-mRNAs that must be exten-tion elongation by Pol II (Yang et al., 1996).
A critical finding in support of the hypothesis that sively spliced before the mature mRNA, encoding the
relevant protein product, is ready for translation. Be-Tat acted at the level of CTD phosphorylation was the
observation that immunoprecipitation of Tat resulted in cause these pre-mRNA intermediates would encode
useless or even deleterious proteins if available to thethe specific coimmunoprecipitation of a CTD kinase of
z42 kDa (Yang et al., 1996). Research into factors in- cytoplasmic translational machinery, the eukaryotic cell
has evolved mechanisms to retain incompletely splicedvolved in transcription elongation in Drosophila had
meanwhile identified an essential multicomponent fac- RNAs in the nucleus until splicing is complete. While
the mechanisms that maintain this segregation remaintor, termed positive transcription elongation factor b
(P-TEFb), that included a novel CTD kinase with homol- to be fully elucidated, this is likely to involve the recogni-
tion of unused 59 splice sites by splicing commitmentogy to cyclin-dependent kinases (CDKs) (Zhu et al.,
1997). Identification of the human homolog of this pro- factors such as the U1 small nuclear ribonucleoprotein
particle and members of the serine-arginine-rich classtein, now called CDK9, revealed that this was also z42
kDa in size. It was rapidly demonstrated that the kinase of splicing factors.
While the nuclear retention of incompletely splicedthat associates with Tat in vivo was indeed CDK9 and
that CDK9 mutants lacking kinase activity could selec- RNAs is undoubtedly benefical to the host cell, this pre-
sents retroviruses in general, and complex retrovirusestively inhibit Tat function (Zhu et al., 1997).
While the identification of CDK9 as a critical mediator in particular, with a serious problem (reviewed by Cullen,
1995). Because HIV-1 contains only the single LTR pro-of Tat function represented a key step forward, the story
remained incomplete. Thus, although CDK9 associated moter element, it encodes only a single, genome-length
primary transcript. Yet expression of the nine open read-with Tat in vivo, no direct interaction between Tat and
CDK9 could be demonstrated in vitro, thus making it ing frames encoded by HIV-1 requires that this single
transcript be expressed in the cytoplasm as an un-likely that this interaction was indirect. Could the ex-
pected cyclin partner for CDK9 be the missing link? In spliced mRNA that serves both as the viral genome and
as the mRNA for Gag and PolÐas one of five singlyfact, recent data from Wei et al. (1998) demonstrate that
the Tat activation domain, but not mutant forms thereof, spliced mRNAs, encoding Vif, Vpr, Vpu, and Env and
lastly as one of the 16 multiply or completely splicedis able to interact directly with a protein termed cyclin
T that, in turn,can bind specifically toCDK9. Importantly, mRNAs encoding Tat, Rev, and Nef. Because splicing
of HIV-1 RNA transcripts is performed entirely by cellularthe Tat±cyclin T complex binds to TAR with high affinity
and specificity in vitro in an interaction that is dependent proteins, the generation of singly and multiply spliced
viral mRNAs requires that the viral genome encode 59on the integrity of not only the bulge but also the loop
of TAR. Particularly satisfying is the observation that and 39 splice sites that can be recognized by cellular
splicing factors. However, the presence of such splicecyclin T is encoded on human chromosome 12 and that
overexpression of human cyclin T in mouse cells rescues sites leads to the nuclear retention of incompletely
spliced viral transcripts and hence precludes expressionTat transcriptional activation via the HIV-1 TAR element.
Therefore, the role of Tat appears to be to bind the cyclin of proteins encoded by the unspliced (Gag, Pol) and
singly spliced (Env, Vif, Vpr, Vpu) viral mRNAs. NoteT subunit of P-TEFb and to recruit P-TEFb to the HIV-1
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however that HIV-1 transcripts that do not retain unutil-
ized 59 splice sites, i.e. the fully spliced mRNAs encoding
Tat, Rev and Nef, are not subject to nuclear retention.
To overcome this problem, HIV-1 has adopted two
strategies. The first is that the splice sites present in the
HIV-1 genome are designed to be inefficient. While this
is not, in and of itself, sufficient to permit the nuclear
export of incompletely spliced HIV-1 transcripts, it does
permit a pool of such RNAs toaccumulate in thenucleus.
Second, HIV-1 has evolved a sequence-specific nuclear
RNA export factor, termed Rev, that is able to induce
the efficient nuclear export, and hence expression, of
the various incompletely spliced viral transcripts (Malim
et al., 1989). Because Rev, Tat, and Nef are encoded by
fully spliced HIV-1 mRNAs, these gene products are
expressed shortly after infection of cells and are there-
fore referred to as early gene products. In contrast, the
Gag, Pol, Env, Vif, Vpr, and Vpu proteins are all depen-
dent on Rev for the nucleocytoplasmic transport of their
cognate mRNAs and are therefore expressed with de-
layed kinetics. These six proteins are therefore referred
to as late HIV-1 proteins.
The z116 aa Rev protein contains an arginine-rich
stretch located toward the amino terminus that serves
as both an ARM and as an NLS (reviewed by Cullen,
1995). This is, in turn, closely flanked on both sides by
residues that mediate Rev multimerization. Unlike the
Tat ARM, the ARM present in Rev is fully able to mediate
binding to its cognate RNA target site without the assis-
Figure 2. Overview of the Steps Involved in Rev Nucleocytoplasmictance of a cellular cofactor. The RNA target for Rev is
Shuttling
a 234-nucleotide RNA stem-loop structure called the
Numbers are referred to in the text.
Rev response element (RRE) encoded within the HIV-1
env gene (Malim et al., 1989). Rev binds, most probably
interact directly with nucleoporins (Mattaj and Engl-as a monomer, to an RNA bulge within the RRE. This
meier, 1998). Binding of import factors, such as Imp b,initial binding event then serves to nucleate the recruit-
or export factors, such as Crm1, to cargo proteins is inment of additional Rev monomers to the RRE in a multi-
turn regulated by the G protein Ran, which is found inmerization process that requires both protein±protein
the GTP-bound form in the nucleus and in the GDP-and protein±RNA interactions and that is critical for Rev-
bound form in the cytoplasm. The proposed steps in themediated nuclear RNA export. The second functional
Rev nucleocytoplasmic transport cycle are numbered indomain in Rev is an z10 aa leucine-rich sequence, lo-
Figure 2.cated between residues 75 and 84, that functions as a
After synthesis, the Rev protein directly interacts withnuclear export signal (NES) both in Rev and when
Imp b via its NLS (1) (Henderson and Percipalle, 1997).attached to other substrate proteins (Fischer et al.,
This is actually unusual, in that most basic NLS proteins1995). Because Rev contains both an NLS and an NES,
interact with an adaptor protein, termed Importin a (Impit rapidly shuttles back and forth between the nucleus
a), that in turn binds to Imp b. In either case, Imp b,and the cytoplasm of expressing cells.
together with its protein cargo, is then recruited to theInitial efforts to identify a protein that mediated the
nuclear pore by a direct Imp b±nucleoporin interactionbiological activity of the Rev NES, using the yeast two-
(2). The process by which translocation into the nucleo-hybrid assay, demonstrated a highly specific interaction
plasm then occurs is unclear; however, Imp-mediatedbetween the Rev NES and certain components of the
nuclear import is known to require energy and may in-nuclear pore, termed nucleoporins. Because nuclear
volve the ordered, sequential interaction of Imp b withpores regulate all nucleocytoplasmic transport (reviewed
specific nucleoporins. Once the Imp b±Rev NLS com-by Mattaj and Englmeier, 1998), this result was exciting
plex reaches the nucleus, where Ran±GTP is present atin that it suggested that Rev might act directly to recruit
high levels, the direct interaction of Imp b with Ran±GTPRRE-containing RNAs to the nuclear pore and hence to
results in release of the Rev cargo (3).the cytoplasm. More recently, it has become apparent
The next step in the Rev pathway involves the specificthat this interaction, while real, is in fact bridged by a
assembly of multiple Rev molecules onto the RRE andprotein, called Crm1, that is highly conserved between
recruitment of Crm1 to the Rev NES sequences therebyyeast and humans (Fornerod et al., 1997; Neville et al.,
assembled onto the target HIV-1 transcript (4). As noted1997; Stade et al., 1997). Crm1 is a member of a group
above, Crm1 is a member of the same family of nucleo-of related proteins, of which the prototype is Importin
cytoplasmic transport factors as Imp b and shares ab (Imp b), that mediate the regulated nuclear import and
export of proteins and RNAs and that are known to conserved Ran±GTP-binding domain. However, while
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Ran±GTP binding by import factors such as Imp b in- the possibility that Nef was acting as a connector be-
tween CD4 and the cellular endocytic machinery.duces the nuclear release of cargo proteins, Ran±GTP
binding is a prerequisite for binding of cargo proteins Internalization of cell surface receptors via CCPs re-
quires the action of adaptor protein (AP) complexes thatby nuclear export factors such as Crm1. The resultant
ribonucleoprotein complex, consisting of the RRE RNA bind to both clathrin and either directly to the receptor
itself or indirectly, via a connector protein. AP com-and multiple Rev, Crm1 and Ran±GTP molecules, is then
recruited to the nuclear pore via the direct interaction plexes exist in two major varieties termed AP-1, found
in the TGN, and AP-2, found at the plasma membrane.of Crm1 with nucleoporins referred to above (5). The
translocation through the nuclear pore that follows is While both AP complexes are heterotetramers of similar
size and structure, there are no subunits in common.again not understood, but can be viewed as the mirror
image of the import translocation mediated by Imp b. Analysis of the ability of Nef to interact with the various
subunits of AP-1 and AP-2 has recently demonstratedOnce the HIV-1 RNA cargo reaches the cytoplasm, the
Ran GTPase activating protein (RanGAP), acting in con- that Nef can directly interact with both the m1 compo-
nent of AP-1 and the related (40% identity) m2 compo-cert with Ran Binding Protein 1 (RanBP1), induces the
hydrolysis of Crm1 bound Ran-GTP to Ran-GDP (6). This nent of AP-2 (Le Gall et al., 1998; Piguet et al., 1998).
As AP-2 is the adaptor present at the plasma membrane,releases both Ran and Crm1 from the Rev NES. It is
unclear how Rev is released from the HIV-1 RNA, al- and as internalization from the plasma membrane is the
major mechanism for CD4 down-regulation, it appearsthough this could reflect competition from cytoplasmic
Imp b for binding to the Rev basic domain. At this point, probable that CD4 internalization primarily results from
the recruitment of CD4 to CCPs due to the direct interac-the cargo HIV-1 RNA is available for translation of the
encoded late viral protein while Rev is free to once more tion of Nef with both CD4 and the m2 subunit of AP-2.
Down-Regulation of Cell Surface MHC Ireturn to the nucleus.
In addition to CD4, Nef also induces the specific down-
regulation of cell-surface MHC I receptors, albeit with
Nef: Numerous Effector Functions somewhat lower efficiency (Le Gall et al., 1998). MHC I
The third early protein encoded by HIV-1, termed Nef, down-regulation results from both the internalization of
is not only the largest auxiliary protein, at z206 aa in cell-surface MHC I receptors and from the sorting of
length, but is also expressed in far higher levels than MHC I molecules from the TGN into AP-1-containing
Tat and Rev. Nevertheless, Nef was initially found to clathrin-coated vesicles. This down-regulation requires
exert a quite modest effect on the rate of HIV-1 replica- specific sequences in the MHC I cytoplasmic tail includ-
tion in culture, with some early reports even suggesting ing a key tyrosine residue (Greenberg et al., 1998; Le
that Nef was a negative factor. However, thesubsequent Gall et al., 1998). No leucine motif, similar to that required
demonstration that inactivation of the nef gene in a for CD4 down-regulation, exists in MHC I.
pathogenic clone of simian immunodeficiency virus (SIV) Because MHC I is required to present viral peptide
caused a dramatic drop in both viral titer and pathogenic epitopes to cytotoxic T lymphocytes (CTL), down-regu-
potential in infected macaques, revealed that Nef was lation of cell surface MHC I could inhibit the CTL-medi-
critically important in vivo (Kestler et al., 1991). More ated lysis of HIV-1-infected cells, and this has indeed
recent research has demonstrated that Nef exerts at been recently demonstrated (Collins et al., 1998). Al-
least three distinct activities in infected cells. though this result might suggest that MHC I down-regu-
Down-Regulation of Cell Surface CD4 lation is the major contributor to the in vivo Nef pheno-
The first clear activity to be assigned to Nef was down- type, this may not be the case as a clear positive effect
regulation of cell surface CD4 expression (Garcia and of Nef on viral replication in vivo is seen in SIV-infected
Miller, 1991). CD4 is the primary receptor for HIV-1 and macaques by two weeks after infection (Kestler et al.,
down-regulation would therefore be predicted to reduce 1991), i.e., before an effective CTL response can be
the formation of complexes between CD4 and newly mounted by the infected animal. The fact that a readily
synthesized HIV-1 Envelope protein on the infected cell detectable anti-HIV-1 CTL response is observed in most
surface and also to facilitate the release of HIV-1 virions infected individuals (reviewed by McMichael, 1998 [this
(Benson et al., 1993). The Nef protein is posttransla- issue of Cell]) further demonstrates that the Nef-medi-
tionally modified by myristoylation of its amino terminus, ated inhibition of antigen presentation via MHC I is
and this modification targets Nef to the inner surface of clearly incomplete.
the plasma membrane and to the trans-Golgi network Analysis of the Nef protein demonstrates that CD4
(TGN). It is believed that Nef binds the cytoplasmic tail and MHC I down-regulation can be, at least in part,
of CD4 directly, although this remains to be fully proven. mutationally segregated (Greenberg et al., 1998). How-
Downregulation of cell surface CD4 is a specific event ever, as the cytoplasmic tails of CD4 and MHC I display
requiring a cluster of leucine and isoleucine residues in no sequence homology, this segregation could simply
the CD4 cytoplasmic tail and results from the targeting reflect the selective disruption of the MHC I and CD4
of CD4 into clathrin coated pits (CCPs) followed by inter- targeting functions of Nef. At present, the simplest inter-
nalization and transport to lysosomes, where CD4 is pretation of the available data is that Nef connects both
degraded (Aiken et al., 1994). Direct fusion of Nef to CD4 and MHC I to the intracellular protein sorting ma-
the extracellular and transmembrane domains of CD4 chinery by binding to CD4 or MHC I on the one hand
recapitulates the phenotype seen when Nef is expressed and either AP-1 or AP-2 on the other. Regardless of
in trans, i.e. the CD4-Nef fusion protein is also internal- whether AP-1 or AP-2 is recruited, which may largely
depend on whether recruitment occurs at the TGN orized via CCPs and degraded. This observation raised
Review: HIV Auxiliary Proteins
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at the plasma membrane, these target proteins are then effect of Nef on cellular activation represents an inde-
pendent phenotype or whether this is likely to be impor-sorted into clathrin-coated vesicles that deliver them for
degradation in lysosomes. tant in vivo.
In conclusion, it is clear that Nef exhibits a numberEnhanced Virion Infectivity
In addition toa possibleenhancement in virion infectivity of distinct activities that undoubtedly each contribute
to the marked increase in viral replication and pathoge-due to CD4 down-regulation, Nef also enhances virion
infectivity by a second, entirely CD4-independent mech- nicity displayed by Nef expressing HIV-1 and SIV in vivo.
Definition of the precise contribution of each activity toanism (Spina et al., 1994). This enhancement is con-
ferred by Nef during the process of virion assembly and the overall in vivo phenotype will require a far more
complete understanding of the domain organization ofcannot be complemented by expression of Nef in target
cells. While the effect of Nef on virion infectivity is quite Nef than currently exists. Once this is achieved, it may
then be possible to design mutations that selectivelymodest in most culture settings, this effect may increase
to 10-fold or more when primary T cells are infected inactivate specific Nef functional domains and then as-
sess their effect on viral replication and pathogenesiswith HIV-1 while quiescent and then subsequently acti-
vated or if certain highly susceptible target cells, such in vivo.
as CD41-HeLa cells, are used.
While HIV-1 virions produced in the presence and Vif: Virion Infectivity Factor
The Vif protein is encoded by a singly spliced mRNAabsence of Nef do not differ in terms of cell-free reverse
transcriptase activity or in terms of their ability to bind whose expression is Rev dependent, and Vif is therefore
a late HIV-1 gene product. Vif is z192 aa in length andto and enter target cells, they are less able to complete
proviral DNA synthesis. While Nef does not cause any is expressed at high levels in the cytoplasm of infected
cells. A substantial fraction of Vif is membrane associ-major change in the morphology or composition of viri-
ons, two differences have been reported. First, Nef itself ated and colocalizes with the HIV-1 Gag protein, a prop-
erty that is likely to be important for its biological activity.is packaged into virions at low efficiency (#10 molecules
per virion) and even undergoes specific processing by The only known biological activity of Vif is to enhance
the infectivity of HIV-1 virions produced in primary Tthe HIV-1 protease. While this finding may be important,
it could also simply reflect a low level of nonspecific cells, and in ªnonpermissiveº cell lines such as H9, by
z100-fold (Gabuzda et al., 1992). In contrast, virionspackaging of the membrane-associated Nef protein into
virions during viral budding from the cell membrane. It produced in ªpermissiveº cell lines such as CEM-SS are
equivalently infectious whether Vif is present or not. Ithas also been reported that serine phosphorylation of
the matrix component of HIV-1 Gag is modified in Nef- remains unclear whether this phenomenon reflects the
presence of an inhibitor of viral replication in nonpermis-expressing cells. Nef has previously been reported to
associate specifically with a serine kinase related to sive cells that is inactivated by Vif or, alternately, the
existence of a factor in permissive cells that substitutesp21-activated kinase (PAK), and it is therefore possible
that Nef may recruit a PAK-like kinase to sites of virion for Vif. The nonpermissive state appears most physio-
logically relevant, both because this is the phenotypeassembly (Swingler et al., 1997). While a Nef-induced
change in the phosphorylation state of matrix could cer- of primary cells in culture and because vif2 SIV replicates
extremely poorly in vivo.tainly affect virion infectivity, this hypothesis remains to
be proven. Vif-enhanced infectivity is conferred in the virus-pro-
ducing cell yet only manifests itself in the target cell.Effects on Cellular Signal Transduction
and Activation vif2 proviruses can therefore be complemented in trans
in virus-producing cells but not in target cells. AnalysisWhile there have been number of reports documenting
effects of Nef on signal transduction pathways and on of HIV-1 virions produced by nonpermissive cells in the
presence and absence of Vif has failed to document anythe activation state of both lymphoid and nonlymphoid
cells, no clear consensus exists as to cellular targets or quantitative or qualitative difference in the incorporation
or processing of viral structural proteins, although thereeven as to whether the effect of Nef is positive or nega-
tive. Clearly, the possibility exists that these reported are reports suggesting that vif2 viruses are more likely
to exhibit an aberrant morphology. One clear differenceeffects are entirely secondary to the more fully docu-
mented properties of Nef listed above. For example, is that between 10 and 100 molecules of Vif are pack-
aged into virions produced in the presence of Vif. WhileNef-induced degradation of CD4 is known to result in
the release of the normally CD4-bound tyrosine kinase this incorporation could certainly be important for the
Vif phenotype, it remainsuncertain whether this incorpo-lck, and this could have a marked effect on signaling
via, for example, the TCR/CD3 complex. In addition, Nef ration is specific as murine leukemia virus, which lacks
a protein equivalent to Vif, is able to package Vif withis believed to recruit a serine/threonine kinase related
to PAK to the plasma membrane and also contains an comparable efficiency (Camaur and Trono, 1996).
There is general agreement that defective vif2 virionsSH3-binding motif that could interact with membrane-
bound tyrosine kinases or other signaling molecules. By can bind to, and penetrate into, target cells effectively
and are also able to initiate reverse transcription (Simonjuxtaposing enzymes and proteins that are not normally
in contact, Nef may either inadvertently or intentionally and Malim, 1996). There is also general agreement that
reverse transcription fails to go to completion, althoughmodulate the activation state of the cell. At present, the
assays used to measure these effects, and the range of there is some controversy as to the precise stage at
which failure occurs. In any event, although the preinte-Nef mutants that have been analyzed, do not permit any
clear statement to be made as to whether the reported gration complex (PIC) reaches the nucleus, little or no
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full-length provirus is produced and the partial reverse interaction of Vpr with nucleoporins and Imp a appears
likely to be critical for its role in HIV-1 PIC nuclear importtranscripts that are synthesized are rapidly degraded. It
therefore appears that Vif, acting in the virus-producing and, hence, in enhancing HIV-1 replication in macro-
phages and other nondividing cells.cells, somehow modifies HIV-1 virions in a way that
confers enhanced postpenetration stability and function In addition to its role in nuclear import, Vpr has a
second, distinct activity in expressing cells, inductionon PICs in target cells.
Although no cellular target for Vif is as yet known, of arrest in the G2 phase of the cell cycle, that maps to
an z26 aa carboxy-terminal basic domain. Cells ex-recent data demonstrate that such a target must exist
(Simon et al., 1998). Specifically, while HIV-1 Vif can pressing Vpr contain very low levels of p34cdc2±cyclin B
kinase activity, although both proteins are expressedcomplement the infectivity of vif2 HIV-1 and SIVAGM viri-
ons produced in nonpermissive human cells, SIVAGM Vif (Re et al., 1995). The activity of the p34cdc2±cyclin B ki-
nase is critical for the transition from G2 to mitosis andis inactive. In contrast, SIVAGM Vif can complement vif2
HIV-1 and SIVAGM produced in simian cells, while HIV-1 requires the removal, by the phosphatase cdc25C, of
phosphate residues on p34cdc2 that inhibit kinase func-Vif is inactive. These data not only demonstrate that
Vif function is dependent on the presence of a cellular tion. However, in Vpr-expressing cells, cdc25C is in an
inactive form, thus suggesting that the target for Vprcofactor but also reveal that different immunodeficiency
virus Vif proteins have evolved a considerable degree function is likely to be an upstream regulator of the G2
to M transition.of primate species specificity. This result is of interest
given current efforts to develop simian and murine mod- An interesting rationale for the Vpr-mediated arrest of
cells in G2 is provided by the recent observation thatels that can support a high-titer, pathogenic infection
by HIV-1. the HIV-1 LTR promoter is more active in G2-arrested
cells (Goh et al., 1998). Arrest of cells in G2 by either
Vpr or by overexpression of a dominant negative form
Vpr: Nuclear Import and G2 Arrest of p34cdc2,was shown to activate theHIV-1 LTRpromoter
The Vpr protein is a late HIV-1 gene product of z96 aa to an equivalent degree. Therefore, the mild stimulatory
in length that is packaged into the virion nucleocapsid effect of Vpr on the LTR promoter, which had been noted
in molar amounts equivalent to those of the Gag protein. previously by others, is likely to be entirely indirect. The
Vpr may therefore be viewed as a virion structural pro- importance of this enhancement is, however, unclear
tein. Packaging into virions is mediated by the p6 pro- given that theeffect of Vpr on the rate of HIV-1 replication
tein, located at the very carboxy terminus of the p55 in rapidly dividing T cells in culture, which should be
Gag precursor, and also requires specific sequences highly responsive to G2 arrest, is minor (Heinzinger et
located toward the center of Vpr (Paxton et al., 1993). al., 1994; Vodicka et al., 1998).
Analysis of the effect of Vpr on HIV-1 replication dem-
onstrated a modest positive effect in T cell lines and
primary T cells but a far more marked effect on HIV-1 Vpu: Unique to HIV-1
While the other auxiliary proteins of HIV-1 are conservedreplication in growth-arrested cells, such as primary
macrophages. This effect is thought to reflect an impor- in some or all of the animal lentiviruses (Tat, Rev, and
Vif) or at least in all primate immunodeficiency virusestant role for Vpr in mediating the nuclear import of HIV-1
PICs into the nucleus of, particularly, nondividing cells (Nef and Vpr), Vpu appears unique to HIV-1 and the
closely related SIVcpz isolates. Vpu is an oligomeric inte-(Heinzinger et al., 1994). Nuclear import of HIV-1 PICs
is an active process that is believed to require an array gral membrane protein consisting of an amino-terminal
transmembrane domain and a carboxy-terminal cyto-of NLS sequences provided by the matrix protein, by
integrase, and also by Vpr. The Vpr NLS, which extends plasmic tail. Vpu serves two independent functions in
the HIV-1 life cycle: enhancement of virion release fromover essentially the entire amino-terminal 70 aa of Vpr,
is a nonconventional NLS, i.e., distinct from the basic infected cells and the selective degradation of CD4 in
the cell endoplasmic reticulum (ER).NLS prototype. Interestingly, fusion of a carrier protein,
such as b-gal, to the Vpr NLS induces not only nuclear Simultaneous synthesis of both HIV-1 envelope and
CD4 in a single cell results in the formation of Env±CD4import, but also a marked accumulation of the fusion
protein at nuclear pores (Vodicka et al., 1998). A search complexes in the ER that are retained and eventually
degraded. Vpu directly interacts with a specific targetfor potential cellular target proteins for Vpr has demon-
strated that Vpr can directly interact with a subset of sequence in the cytoplasmic tail of CD4, distinct from
that seen by Nef, to target CD4 to an ER-associatednucleoporins, thus potentially explaining this localiza-
tion. In addition, Vpr can also bind to Imp a, the adaptor protein degradation pathway. This permits the release
of Env from the ER and its subsequent incorporationprotein that normally mediates the interaction of basic
NLS sequences with the Imp b nuclear import factor into progeny virions (Willey et al., 1992).
The mechanism by which Vpu targets CD4 for prote-(Mattaj and Englmeier, 1998). However, the binding sites
for Vpr and basic NLSs on Imp a are distinct and this olysis has recently been resolved (Margottin et al., 1998).
Vpu, via its cytoplasmic tail, binds to CD4 moleculesinteraction is not believed to recruit Vpr to Imp b (Popov
et al., 1998). While the reason for the interaction of Vpr that have been retained in the ER and also recruits a
cellular factor termed h-bTrCP to the ER membrane.with Imp a is therefore uncertain, it has been proposed
that it could enhance the affinity of Imp a for basic NLSs The h-bTrCP protein consists of a series of WD repeat
elements, which bind Vpu, and a so-called F box, whichpresent on HIV-1 PICs, and thereby enhance PIC import
into the nucleus (Popov et al., 1998). In any case, the recruits a cellular targeting factor for ubiquitin-mediated
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12 is required for optimal interactions between Tat and TAR of
Table 1. Biological Activities of Several HIV-1 Auxilary Proteins human immunodeficiency virus type 1 in rodent cells. J. Virol. 66,
4617±4621.Auxiliary
Protein Activity Mechanism Benson, R.E., Sanfridson, A., Ottinger, J.S., Doyle, C., and Cullen,
B.R. (1993). Downregulation of cell-surface CD4 expression by sim-Tat Transcriptional activation Recruitment of cyclin T
ian immunodeficiency virus Nef prevents viral super infection. J.of HIV-1 LTR to TAR RNA
Exp. Med. 177, 1561±1566.Rev Nuclear Export of late Recruitment of Crm1 to
Camaur, D., and Trono, D. (1996). Characterization of human immu-HIV-1 mRNAs RRE RNA
nodeficiency virus type 1 Vif particle incorporation. J. Virol. 70, 6106±Nef Down-regulation of cell Recruitment of AP-1 or
6111.surface AP-2 to CD4
Collins, K.L., Chen, B.K., Kalams, S.A., Walker, B.D., and Baltimore,Nef Down-regulation of cell Recruitment of AP-1 or
D. (1998). HIV-1 Nef protein protects infected primary cells againstsurface AP-2 to MHC I
killing by cytotoxic T lymphocytes. Nature 391, 397±401.Vpu Degradation of CD4 in Recruitment of h-bTrCP
the ER to CD4 Cullen, B.R. (1995). Regulation of HIV gene expression. AIDS 9,
19±32.
Fischer, U., Huber, J., Boelens, W.C., Mattaj, I.W., and LuÈ hrmann,
R. (1995). The HIV-1 Rev activation domain is a nuclear export signalproteolysis termed Skp1. This recruitment targets CD4
that accesses an export pathway used by specific cellular RNAs.for degradation, most probably by the proteasome,
Cell 82, 475±483.
while Vpu is apparently recycled (Margottin et al., 1998).
Fornerod, M., Ohno, M., Yoshida, M., and Mattaj, I.W. (1997). CRM1
While CD4 degradation is mediated by sequences is an export receptor for leucine-rich nuclear export signals. Cell
located in the Vpu cytoplasmic tail, enhanced virion re- 90, 1051±1060.
lease is dependent on the hydrophobic amino-terminal Gabuzda, D.H., Lawrence, K., Langhoff, E., Terwilliger, E., Dorfman,
transmembrane domain. Vpu appears to facilitate virion T., Haseltine, W.A., and Sodroski, J. (1992). Role of vif in replication
of human immunodeficiency virus type 1 in CD41 T lymphocytes.release both by promoting the budding of virions from
J. Virol. 66, 6489±6495.plasma, as opposed to intracytoplasmic, membrane
Garcia, J.V., and Miller, A.D. (1991). Serine phosphorylation-inde-structures and by facilitating the release of budding viri-
pendent downregulation of cell-surface CD4 by nef. Nature 350,ons from the membrane (Klimkait et al., 1990). Mutation
508±511.
of Vpu therefore results in a drop in released virus and
Goh, W.C., Rogel, M.E., Kinsey, C.M., Michael, S.F., Fultz, P.N.,in an accumulation of intracellular virus particles. This Nowak, M.A., Hahn, B.H., and Emerman, M. (1998). HIV-1 Vpr in-
effect appears relatively nonspecific, in that Vpu has creases viral expression by manipulation of the cell cycle: a mecha-
also been reported to facilitate the budding of unrelated nism for selection of Vpr in vivo. Nature Med. 4, 65±71.
retroviruses. Little is known as to the mechanism re- Greenberg, M.E., Iafrate, A.J., and Skowronski, J. (1998). The SH3
domain-binding surface and an acidic motif in HIV-1 Nef regulatesponsible for this effect, although the Vpu membrane
trafficking of class I MHC complexes. EMBO J. 17, 2777±2789.anchor, which is responsible for this phenotype, has
Heinzinger, N.K., Bukrinsky, M.I., Haggerty, S.A., Ragland, A.M.,been proposed to form a cation-selective ion channel.
Kewalramani, V., Lee, M.-A., Gendelman, H.E., Ratner, L., Steven-In vitro analysis of the effect of Vpu on HIV-1 replication
son, M., and Emerman, M. (1994). The Vpr protein of human immuno-rates showed a moderate positive effect and demon-
deficiency virus type 1 influences nuclear localization of viral nucleic
strated that most of this increase results from the virion acids in nondividing host cells. Proc. Natl. Acad. Sci. USA 91, 7311±
release activity of Vpu. 7315.
Henderson, B.R., and Percipalle, P. (1997). Interactions between
HIV-1 Auxiliary Proteins as Molecular Connectors HIV Rev and nuclear import and export factors: the Rev nuclear
localisation signal mediates specific binding to human Importin-b.Much remains to be discovered about the many roles
J. Mol. Biol. 274, 693±707.of the auxiliary proteins of HIV-1 in the viral life cycle,
Kao, S.-Y., Calman, A.F., Luciw, P.A., and Peterlin, B.M. (1987). Anti-and the list of functions delineated above could well be
termination of transcription within the long terminal repeat of HIV-1incomplete. Nevertheless, clear progress in defining the
by tat gene product. Nature 330, 489±493.
mechanisms of action, and cellular targets, for several
Kestler, H.W., III, Ringler, D.J., Mori, K., Panicali, D.L., Sehgal, P.K.,
key auxiliary proteins has now been made. Surprisingly, Daniel, M.D., and Desrosiers, R.C. (1991). Importance of the nef
as summarized in Table 1, it appears that a similar strat- gene for maintenance of high virus loads and for development of
egy has been adopted by several different auxiliary pro- AIDS. Cell 65, 651±662.
teins to achieve a range of distinct biological activities. Klimkait, T., Strebel, K., Hoggan, M.D., Martin, M.A., and Orenstein,
J.M. (1990). The human immunodeficiency virus type 1-specific pro-In particular, it appears that a common mode of action
tein Vpu is required for efficient virus maturation and release. J.for several of these proteins is to act as a molecular
Virol. 64, 621±629.connector between two macromolecules that would
Le Gall, S., Erdtmann, L., Benichou, S., Berlioz-Torrent, C., Liu, L.,otherwise be unable to interact. By this simple expedi-
Benarous, R., Heard, J.-M., and Schwartz, O. (1998). Nef interacts
ent, these small proteins are each able to recruit entire with the m subunit of clathrin adaptor complexes and reveals a
cellular metabolic pathways to the cause of enhancing cryptic sorting signal in MHC I molecules. Immunity 8, 483±495.
the efficiency of virus replication. Malim, M.H., Hauber, J., Le, S.-Y., Maizel, J.V., and Cullen, B.R.
(1989). The HIV-1 rev trans-activator acts through a structured target
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